More Starpharma Holdings Limited news
Starpharma Holdings LimitedASX: SPL

Successful completion of VivaGel study sexually active women

Mar 30, 2016 at 5:31 AM EDT · Issued by Starpharma Holdings Limited

Filed with ASX · Mar 30, 2016 at 5:31 AM EDT

On 6ix: 6ix.com/news/successful-completion-of-vivagel-study-sexually-active-women

View Attachment

6ix hasn’t read this filing yet.

Starpharma Holdings Limited on 6ix

Earlier from Starpharma

  • Starpharma`s partner SSL acquired by Reckitt BenckiserMar 30, 2016
  • Starpharma Expands Lilly PartnershipMar 30, 2016
  • Response to an ASX Price QueryMar 30, 2016
  • Starpharma secures FDA agreement on BV treatment Phase 3Mar 30, 2016
  • Starpharma secures European (EMA) agreement on BV Phase 3Mar 30, 2016

Later from Starpharma

  • Starpharma signs drug delivery license with AstraZenecaMar 30, 2016
  • DEP cabazitaxel shows complete, sustained tumour regressionApr 4, 2016
  • VivaGel active against Zika virusMay 5, 2016
  • Starpharmas DEP eliminates cabazitaxel neutropeniaMay 25, 2016
  • Appendix 4C - Quarterly Cashflow ReoprtJul 13, 2016
All Starpharma news releases↗

Follow Starpharma into a list and get an email when it puts out news.

Follow Starpharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer